BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36228378)

  • 21. Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions.
    Mehta K; Behl T; Kumar A; Uddin MS; Zengin G; Arora S
    Curr Protein Pept Sci; 2021; 22(1):4-18. PubMed ID: 33292149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise and Nutraceuticals: Eminent Approach for Diabetic Neuropathy.
    Kale MB; Bajaj K; Umare M; Wankhede NL; Taksande BG; Umekar MJ; Upaganlawar A
    Curr Mol Pharmacol; 2022; 15(1):108-128. PubMed ID: 34191703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.
    Shen H; Zhao J; Liu Y; Sun G
    J Diabetes Res; 2018; 2018():3458615. PubMed ID: 30116739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving Insights into the Pathophysiology of Diabetic Neuropathy: Implications of Malfunctioning Glia and Discovery of Novel Therapeutic Targets.
    Rahman MH; Jha MK; Suk K
    Curr Pharm Des; 2016; 22(6):738-57. PubMed ID: 26635266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation: therapeutic targets for diabetic neuropathy.
    Zhou J; Zhou S
    Mol Neurobiol; 2014 Feb; 49(1):536-46. PubMed ID: 23990376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review.
    Pathak R; Sachan N; Chandra P
    Biomed Pharmacother; 2022 Jun; 150():113025. PubMed ID: 35658222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Diabetic Neuropathy: Focus on Oxidative Stress.
    Pang L; Lian X; Liu H; Zhang Y; Li Q; Cai Y; Ma H; Yu X
    Oxid Med Cell Longev; 2020; 2020():9524635. PubMed ID: 32832011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy.
    Bönhof GJ; Herder C; Ziegler D
    Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs for diabetic neuropathy.
    Tahrani AA; Askwith T; Stevens MJ
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):661-83. PubMed ID: 20795891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological evaluation of Thuja occidentalis for the attenuation of neuropathy via AGEs and TNF-α inhibition in diabetic neuropathic rats.
    Bhargava SK; Singh TG; Mannan A; Singh S; Singh M; Gupta S
    Environ Sci Pollut Res Int; 2022 Aug; 29(40):60542-60557. PubMed ID: 35420347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline-a review.
    Siddiqui S; Deshmukh AJ; Mudaliar P; Nalawade AJ; Iyer D; Aich J
    J Egypt Natl Canc Inst; 2022 Aug; 34(1):33. PubMed ID: 35934727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
    Mittal N; Mittal R
    Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic Neuropathy Pain Management: A Global Challenge.
    Qureshi Z; Ali MN
    Curr Diabetes Rev; 2021; 17(5):e031120187542. PubMed ID: 33143631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular property diagnostic suite for diabetes mellitus (MPDS
    Gaur AS; Nagamani S; Tanneeru K; Druzhilovskiy D; Rudik A; Poroikov V; Narahari Sastry G
    J Biomed Inform; 2018 Sep; 85():114-125. PubMed ID: 30092360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic neuropathy: cellular mechanisms as therapeutic targets.
    Vincent AM; Callaghan BC; Smith AL; Feldman EL
    Nat Rev Neurol; 2011 Sep; 7(10):573-83. PubMed ID: 21912405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can diabetic neuropathy be prevented?
    Park TS; Park JH; Baek HS
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic neuropathy: Molecular approach a treatment opportunity.
    Méndez-Morales ST; Pérez-De Marcos JC; Rodríguez-Cortés O; Flores-Mejía R; Martínez-Venegas M; Sánchez-Vera Y; Tamay-Cach F; Lomeli-Gonzaléz J; Emilio Reyes A; Lehman-Mendoza R; Martínez-Arredondo HA; Vazquez-Dávila RA; Torres-Roldan JF; Correa-Basurto J; Arellano-Mendoza MG
    Vascul Pharmacol; 2022 Apr; 143():106954. PubMed ID: 35063655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF gene transfer for diabetic neuropathy.
    Isner JM; Ropper A; Hirst K
    Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors involved in symmetrical distal diabetic neuropathy].
    Gómez-Viera N; Soto-Lavastida A; Roselló-Silva H; Gómez de Molina-Iglesias M
    Rev Neurol; 2001 May 1-15; 32(9):806-12. PubMed ID: 11424028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herbal Remedies: A Boon for Diabetic Neuropathy.
    Tiwari R; Siddiqui MH; Mahmood T; Bagga P; Ahsan F; Shamim A
    J Diet Suppl; 2019; 16(4):470-490. PubMed ID: 29580105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.